The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A

The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A

<p>Abstract</p> <p>Background</p> <p>Amifostine (WR-2721, delivered as Ethyol<sup>®</sup>) is a phosphorylated aminothiol compound clinically used in addition to cis-platinum to reduce the toxic side effects of therapeutic treatment on normal cells without r...

Full description

Bibliographic Details
Main Authors: Bouchecareilh M, Rezvani HR, Canron X, Dedieu S, Mazurier F, Sinisi R, Zanda M, Moenner M, Bikfalvi A, North S
Format: Article
Language:English
Published: BMC 2010-03-01
Series:BMC Medicine
Online Access:http://www.biomedcentral.com/1741-7015/8/19

Similar Items

Similar Items